A study published in the New England Journal of Medicine Wednesday suggests full doses of the blood thinner heparin improved outcomes and decreased the need for life-support for moderately ill COVID-19 patients.
via CBC | Top Stories News
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment